Has the Merck Pharmaceutical Company Killed More People than the U.S. Military or Any Terrorist Organization?

Which private corporation has likely been responsible for the deaths of more innocent people than any terrorist organization or military regime change in Afghanistan, Iraq, Libya, Syria and elsewhere? For us, the answer is evident: Merck and Company. One of the largest scandals in recent medical history was the company's anti-inflammatory drug Vioxx that resulted in fines above $4.8 billion for causing over a minimum 60,000 deaths from sudden heart attacks and over 120,000 serious medical injuries. At its height, Vioxx was earning over $2 billion in revenues annually and it is estimated that 25 million patients were prescribed the medication. The securities class action suit against the company alone reached $1 billion, placing it in the top 15 securities lawsuits in US corporate history. The primary charge was Merck's intentional withholding of scientific data about the drug's adverse cardiovascular side effects.  Years after the settlement, Ron Unz, the publisher of The American Conservative, undertook his own investigation to validate Vioxx's death toll. Analyzing the drug's adverse effects over a longer time period, Unz estimated Merck may have been responsible for nearly half a million premature deaths in elderly patients, the drug's primary target group. That is roughly the same number of total civilian, military and terrorist deaths from the US' military escapades in Afghanistan, Iraq and Pakistan combined.  Merck is America's leading vaccine manufacturer. What is important at this moment is that many corporations are fast-tracking a Covid-19 vaccine, without sufficient long-term animal and human clinical trials, and Merck is now aggressively making efforts to beat out its competition with a Covid-19 vaccine. Do we really want to trust such a company with this reputation with a Covid vaccine?

Not Wanting to Get Left Behind, Merck Nabs $38 MILLION from U.S. Government to Develop COVID Vaccine

Despite the fact that they are currently embattled in two federal lawsuits for fraud regarding the development of their MMR and Gardasil vaccines, Merck jumped into the COVID-19 race and nabbed $38 MILLION of American taxpayer funds to develop COVID products, including vaccines, it was announced today. The transfer of American wealth to the criminal pharmaceutical industry continues as millions are out of work and non-pharmaceutical businesses go bankrupt.

Former CDC Head and Merck’s Current Vaccine Division President Julie Gerberding Sells $9.1 Million in Merck Pharmaceutical Shares as Gardasil Vaccine Gets Bad Press

SEC filings reveal that Merck’s Vaccine Division President Julie Gerberding sold over half her Merck shares in January for $9.1 Million. That transaction followed a spate of bad news for Merck’s flagship Gardasil vaccine. Last month, Cancer Research UK announced an alarming 54% rise in cervical cancer among 24-29-year-olds, the first generation to receive the HPV jabs. The following day, the Journal of the Royal Society of Medicine published a withering critique of Gardasil’s crooked clinical trials, “It is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome.” As Gerberding knows, those trials revealed that Gardasil dramatically RAISES (by+44.6%) the risk of cervical cancer among women with a current infection or those previously exposed to HPV. Merck is now fighting existential fraud lawsuits on both the MMR and Gardasil vaccines, that threaten licensing for those key products. Fat rats are always the first to jump ship.

Is Merck’s 9-Year Long Whistleblower Fraud Lawsuit on the MMR Vaccine Finally Coming to a Resolution?

With all the "measles outbreaks" that brought national headlines earlier this year, and resulted in may states introducing legislation to force vaccinate the public and remove vaccine exemptions for school-age children, one thing the national corporate-sponsored "mainstream" media failed to report, is that the only vaccine available in the U.S. for measles has been involved in an 9-year long legal battle for fraud, due to Merck's own scientists who helped develop the vaccine becoming whistleblowers. First of all, there is no measles vaccine available in the U.S., only a 3 dose combination vaccine for mumps, measles and rubella (MMR), which is licensed to Merck. The mumps portion of the vaccine is what Merck's own scientists have claimed is fraudulent, and not effective. The only time the corporate media, which is heavily funded by the pharmaceutical industry, really covered the lawsuit was two years after it was originally filed back in 2010, when in 2012 a judge unsealed key documents. It is not surprising then that the CDC and other government health agencies are concentrating on cases of measles in the U.S. public, instead of outbreaks of mumps which far exceeds measles outbreaks, and happens primarily among the vaccinated population. Health Impact News has been following the Merck MMR fraud lawsuit for over 6 years now, and we exposed the hypocrisy of government health officials concentrating on measles outbreaks, even though mumps outbreaks are far more serious, earlier this year. Attorney Robert F. Kennedy, Jr. is now reporting that the 9-year-old long MMR fraud lawsuit may be coming to an end, and that U.S. Department of Health and Human Services officials are trying to get the FDA to approve the Glaxo Smith Kline (GSK) version of the MMR vaccine in the U.S. in case the judge rules against Merck. However, there is no evidence that GSK's version of the vaccine is any better.

Judge Protects Merck Pharmaceutical Company Instead of the Public by Allowing Merck to Hide Side Effects of FDA Approved Drugs

A Reuters investigative report reveals how Federal judges are complicit in shielding pharmaceutical giants like Merck & Co. by allowing the company to conceal the evidence of real risks of harm from widely prescribed drugs. The risks are concealed from physicians and the public. “It goes without saying that the more information a physician has, the more he can share with the patient and the more informed the decision-making process becomes.” —  Nelson Novick, MD Merck’s Corporate Rap Sheet includes court adjudicated lawsuit findings against the company which has paid multi-billion dollars in settlements for False Claims, Product Safety/Concealment of serious adverse effects, Bribery, Tax fraud, and more. Multiple Merck products caused severe harm, including deaths; these include: the arthritis drug Indocin®  (1960s); the widely prescribed drug for pregnant women, diethylstilbestrol (DES)®  drug that caused women vaginal cancer (1970s); Vioxx®, the painkiller prescribed for arthritis (1999-2004) caused, 140,000 heart attacks and an estimated30 to 60,000 deaths. Merck paid $4.85 Billion to settle Vioxx lawsuits.  Another controversial drug is Fosamax®  prescribed for osteoporosis (1990s) which causes osteonecrosis of the jaw and thighbone fractures; Januvia® , linked to pancreatitis, pancreatic cancer, and severe joint pain. A Reuters investigative reporter Dan Evine, reveals how Judge Brian Cogan – who sat in judgment over 900 Propecia®  lawsuits in New York federal court – enabled Merck to conceal the documents that proved the company’s culpability.

Merck Continues to Make Hundreds of Millions on Measles Vaccine – 58% Increase After 2019 Measles “Outbreak”

Sales of Merck's measles vaccine, the MMR combo vaccine that also includes mumps and rubella, continues to soar as Merck reported this week that in the second quarter of 2019, sales for the measles vaccine were 58% higher than the year before, at $675 million. As CNBC reports: "Pharmaceutical giant Merck said Tuesday that high consumer demand for its measles vaccines, amid the largest U.S. outbreak in decades, helped boost sales in its second quarter. Sales of children’s vaccines, which includes the New Jersey-based company’s MMR vaccine, for measles, mumps and rubella, jumped 58% year over year to $675 million, Merck announced in its second-quarter earnings report Tuesday. Merck, which is the sole U.S. supplier of measles vaccines, said the strong growth was due in part to this year’s measles outbreak..." Is there any other sector of the U.S. economy that is more profitable than vaccines? Consider these facts: 1. The U.S. Government gave legal immunity to pharmaceutical companies in 1986, because Big Pharma threatened Congress by stating they would stop manufacturing and selling vaccines due to the many lawsuits brought against them for vaccine injuries. Vaccines have proliferated in the market place since 1986 as a result, with the CDC recommending up to 69 doses of vaccines to children before they reach the age of 18. 2. In most states, the CDC recommended vaccine schedule is required for children at attend school. 3. The U.S. Government owns several patents on vaccines, and the CDC is the largest purchaser of vaccines, using U.S. taxpayer funds to purchase more than $5 billion in vaccines each year. Is there any other market in the U.S. where there is virtually no liability for your products, the government requires you to purchase the product, and the government itself is the largest customer of those products? Also, most vaccines have only one manufacturer approved by the U.S. government for sale in the U.S., such as the MMR vaccine, creating a monopoly for that product. And if that is not enough to ensure business success, local health departments can pick and choose which illnesses should be classified as "outbreaks" which are then announced by the compliant corporate media, largely funded by the pharmaceutical industry, to boost sales of a vaccine even more.

Gardasil Vaccine on Trial: Attorney Robert F. Kennedy, Jr. Exposes Merck Corruption

Robert F. Kennedy, Jr. is one of the attorneys in the Jennifer Robi vs. Merck and Kaiser Permanente fraud case currently being litigated in Los Angeles Superior Court. This must-watch video, referencing much of the science presented as evidence during the trial, details the many problems with the development and safety of Merck’s third-highest grossing product, Gardasil. Children’s Health Defense (CHD) and Robert F. Kennedy, Jr., CHD’s Chairman and Chief Legal Counsel, ask that you watch and share this video so that you, and others, may make an informed decision of whether or not to give your child, boy or girl, a Gardasil vaccine. It can also be a useful tool for pediatricians who are trying to understand how this vaccine, that is actually causing health problems with young people, could have been approved by FDA and then recommended by CDC. The video is full of jaw-dropping facts about Gardasil and the clinical trials leading up to its release upon an unsuspecting public.

Merck Profits Soar As MMR Measles Vaccine Increases 27% to $496 Million in 2019

There is nothing like a good "measles outbreak" to boost sales when you have a monopoly on the only measles vaccine available, and corporate-funded mainstream media does almost all of your marketing for free, by singing the praises of the vaccine while never mentioning potential side effects or criminal cases currently in place over corruption surrounding the development of the vaccine. Given the fact that U.S. law prevents anyone from suing Merck if a vaccine injury or death occurs from their vaccines, and that the U.S. Government via the CDC is the largest purchaser of vaccines to the tune of $5 billion per year, the vaccine industry has become perhaps the most lucrative market in the history of the world. Merck & Co Inc. reported higher-than-expected first-quarter profits for 2019. Sales of the MMR measles vaccine soared to 27% to $496 million. The company also saw strong sales growth overseas for its Gardasil vaccine, as sales rose 27 percent to $828 million, beating analyst expectations by about $25 million.

Nation’s Leading Lawyers take on Gardasil Vaccine Fraud in U.S. Court

It was truly a red-letter day. Jennifer’s lawyers brilliantly laid bare Merck’s anemic case for Gardasil, dissecting the science in withering presentations challenging both the efficacy and safety of the Gardasil vaccine, and then chronicling the horrifying agency and corporate corruption that lead to its approval. Jennifer Robi is a 24-year-old former athlete and scholar who has been confined to a wheelchair since receiving her third Gardasil vaccines at age sixteen. She suffers continual uncontrolled neuro/muscular contractions (jerking) and postural orthostatic tachycardia syndrome (POTS) and many other symptoms of systemic autoimmune dysregulation. Jennifer’s attorney, Sol Ajalat, initially brought her case in Vaccine Injury Compensation Program and then, following a judgment in the program, elected to proceed in civil court. Since VICA (the Vaccine Injury Compensation Act) forbids recoveries for product defect or negligence, Ajalat brought Jennifer’s civil case under the theories that Merck committed fraud during its clinical trials and then failed to warn Jennifer (and, by implication, other injured girls) about the high risks and meager benefits of the vaccine. In order to support Sol Ajalat and his sons Greg, Larry, and Steve, who compose the Los Angeles firm Ajalat & Ajalat, a blue ribbon A-Team of the nation’s leading plaintiffs’ law firms have joined Jennifer’s trial team. These include the firms most feared by Pharma: Weitz & Luxenberg (countless major pieces of litigation over 30 years), Morgan & Morgan (Vioxx, Phenphen, Breast Implants, Tobacco), Baum Hedlund, (Monsanto $289 million verdict 2018 and the $54 million 2000 verdict against Bayer in Haemophiliac/AIDS case) as well as Children’s Health Defense’s own Robert F. Kennedy, Jr. and Kim Mack Rosenberg (a co-author of The HPV on Trial).

Merck’s Hepatitis B Vaccine Shortage Linked to Reduced Deaths In Babies

In the summer of 2017, a malware virus mainly affecting the Ukraine, found its way onto the mainframe computer systems of Merck wreaking havoc for the company. According to the Wall Street Journal, the incident cost the pharmaceutical giant $670 million to remediate, but more importantly, it caused disruption to the production of two of Merck’s pediatric vaccines: Gardasil 9 (Human Papillomavirus) and Recombivax (Hepatitis B virus), vaccines to help prevent sexually transmitted infections. During the crisis, Merck borrowed from a CDC vaccine stockpile, in order to meet supply commitments for Gardasil 9. However, that was not the case with Recombivax, the Hepatitis B vaccine given to all babies beginning the first day of life. There is growing concern among some scientists about the aluminum adjuvant load in vaccines and its effects on the neurological health of children. Researchers are particularly concerned with Merck’s highly immunogenic adjuvant, Amorphous Aluminum Hydroxyphosphate Sulphate (AAHS). Gardasil and Recombivax are the only vaccines licensed to contain AAHS. We now have more than a year’s worth of data to examine since the attack in 2017 when Engerix-B was introduced. On average there were 29 deaths reported annually for fifteen years prior to the attack (2003 to 2017). In 2018 there were only 6 reported (to end of November 2018). Two of those deaths followed Recombivax.